Question to the Foreign, Commonwealth & Development Office:

To ask Her Majesty’s Government what is their assessment of the importance of the particular focus on Alzheimer’s and Type 1 Diabetes in the third Britain Israel Research and Academic Exchange Partnership Research Call.

The focus of the Britain Israel Research and Academic Exchange Partnership (BIRAX) Initiative is regenerative medicine, which can be applied to many fields of medical research. In addition to the regenerative medicine focus, the Initiative has supported more specific research areas, including Type 1 diabetes and neurodegenerative conditions. These areas have been identified as critical in both Israel and the UK, as well as globally, and as ones in which both countries have particular research expertise. The British Council works with leading research charities in the UK and globally, including British Heart Foundation, Juvenile Diabetes Research Foundation, Multiple Sclerosis Society and Parkinson UK to provide mutual funding, and these areas have been highlighted as areas of joint interest. However it is important to note that it is the quality of the science that drives the BIRAX selection process, and that applications which do not come under these priorities but do meet the criteria have also been selected for funding in past calls. The third call for proposals will continue to evaluate proposals according to criteria outlined in the call’s guidelines and their scientific excellence.

The focus on Alzheimer's and Type 1 Diabetes has the potential to bring upwards of £1.6 million additional funding (to add to the £7 million existing funding raised by the Initiative) to collaborative projects, of which at least 50 per cent is for use in UK universities.